Screener
Nurix Therapeutics, Inc. NRIX Contract Liabilities
Contract Liabilities at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026.
- Filed
- Jul 9, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001549595-26-000040
| Line item | May 31,2026 | November 30,2025 |
|---|---|---|
| Deferred revenue, current | 13,324 | 17,580 |
| Total current liabilities | 72,020 | 86,471 |
| Operating lease liabilities, net of current portion | 54,922 | 52,906 |
| Deferred revenue, net of current portion | 5,971 | 10,011 |
| Total liabilities | 132,913 | 149,388 |
| Commitments and contingencies (Note 6) | ||
| Stockholdersʼ equity: | ||
| Preferred stock, $0.001 par value— 10,000,000 shares authorized as of May 31, 2026 and November 30, 2025; no shares issued and outstanding as of May 31, 2026 and November 30, 2025 | — | — |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Nurix Therapeutics, Inc.'s contract liabilities?
- Nurix Therapeutics, Inc. (NRIX) reported contract liabilities of $5.97M in Q1 2026.
- How has Nurix Therapeutics, Inc.'s contract liabilities changed year-over-year?
- Nurix Therapeutics, Inc.'s contract liabilities decreased by 72.4% year-over-year, from $21.64M to $5.97M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s contract liabilities?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s contract liabilities has grown at a -30.3% compound annual growth rate (CAGR), from $60.69M to $10.01M.
- What does contract liabilities mean?
- Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.
Ask your AI about Nurix Therapeutics, Inc.'s contract liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude